Revital Aricha
Tel Aviv, TA 61580, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis.
Journal: International journal of molecular sciences
Published: May 05, 2024
Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis.
Journal: Arthritis care & research
Published: October 20, 2023
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 16, 2022
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
Journal: JCI insight
Published: May 31, 2022
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Journal: Muscle & nerve
Published: October 08, 2021
MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Journal: Stem cell research & therapy
Published: October 05, 2020
Effects of MSC-NTF cells on T and B regulatory cell function in ALS.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 19, 2020
MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance.
Journal: Frontiers in immunology
Published: November 05, 2019
miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors.
Journal: Stem cell research & therapy
Published: July 23, 2017
Last Updated: 09/26/2026